| Product NDC: | 65649-101 |
| Proprietary Name: | COLAZAL |
| Non Proprietary Name: | balsalazide disodium |
| Active Ingredient(s): | 750 mg/1 & nbsp; balsalazide disodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65649-101 |
| Labeler Name: | Salix Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020610 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000718 |
| Package NDC: | 65649-101-50 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (65649-101-50) |
| NDC Code | 65649-101-50 |
| Proprietary Name | COLAZAL |
| Package Description | 500 CAPSULE in 1 BOTTLE (65649-101-50) |
| Product NDC | 65649-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | balsalazide disodium |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20000718 |
| Marketing Category Name | NDA |
| Labeler Name | Salix Pharmaceuticals, Inc. |
| Substance Name | BALSALAZIDE DISODIUM |
| Strength Number | 750 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |